Delhi is preparing to expand its free newborn genetic-screening programme, bringing specialised testing to more government hospitals across the capital.

The initiative, called Mission ANMOL — Advanced Newborn Monitoring for Optimal Lifecare, is currently being run through the Medical Genetics Lab at Lok Nayak Jai Prakash Hospital (LNJP).

The programme was introduced earlier this year with a target of screening around 250,000 newborns each year for 56 genetic and congenital conditions.

The government now plans to take the service to additional hospitals, potentially making screening easier to access for families across Delhi.

The idea behind the programme is simple: identify health conditions as early as possible so doctors can begin the right investigations and treatment without unnecessary delay.

WHAT IS MISSION ANMOL?

Mission ANMOL is Delhi's newborn-screening programme aimed at identifying certain genetic, metabolic and congenital conditions before they become difficult to manage.

The initiative was announced in the Delhi government's 2026-27 Budget, with newborn screening being offered free of charge.

Testing uses a small blood sample and can identify conditions that may not produce obvious symptoms immediately after birth.

The screening includes conditions such as congenital hypothyroidism, G6PD deficiency and congenital adrenal hyperplasia, along with a wider range of genetic and congenital conditions.

The purpose, however, goes beyond simply conducting tests.

It is about giving doctors an opportunity to act earlier.

LNJP IS THE FIRST MAJOR SCREENING HUB

LNJP Hospital currently houses Delhi's government-run newborn genetic-screening facility.

The Medical Genetics Lab has reportedly been handling around 14,000 newborn samples every month, making it an important centre for the programme.

The facility has specialised laboratory infrastructure and equipment for processing and storing biological samples.

It also provides a central point for doctors and genetic specialists to carry out further investigations when screening results raise concerns.

But Delhi has a large population, and relying on a single specialised facility can make access difficult for families living far from the hospital.

That is one of the main reasons the government is now looking at expansion.

MORE HOSPITALS COULD MEAN EASIER ACCESS

Delhi Health Minister Pankaj Kumar Singh has said the government plans to extend Mission ANMOL to other government hospitals.

The longer-term goal is to make free newborn screening available to every child born in Delhi.

Expanding the programme could increase the number of laboratories involved and reduce the need for families to travel to one central facility.

For parents, that could make the difference between getting a screening done quickly and putting it off because of distance, cost or limited awareness.

A screening programme can only have a broad public-health impact if people can actually access it.

WHY EARLY DETECTION MATTERS

Some genetic and metabolic disorders are difficult to recognise immediately after birth.

A baby can appear perfectly healthy while an underlying condition is already present.

Newborn screening gives doctors an opportunity to identify certain risks before symptoms become more serious.

For some conditions, starting treatment early can make a significant difference to a child's long-term health and development.

This is especially important when delayed diagnosis can result in developmental problems or other complications.

The basic principle is straightforward: the sooner a condition is identified, the sooner doctors can decide what needs to happen next.

ONE SAMPLE, MULTIPLE SCREENINGS

Mission ANMOL has been presented as an effort to expand newborn diagnostics through a single blood sample.

The original Budget announcement included 56 diagnostic tests, with the screening being provided free through the programme.

That could reduce some of the financial pressure associated with genetic and metabolic testing.

For families seeking private diagnostic services, multiple tests or specialist genetic investigations can become expensive.

Government-funded screening can therefore help ensure that the first step toward identifying a potential disorder does not depend entirely on a family's ability to pay.

SCREENING DOES NOT MEAN EVERY CONDITION WILL BE FOUND

There is an important limitation parents need to understand.

Newborn screening is not a complete genetic examination of a child.

Doctors at the LNJP genetics facility have pointed out that newborn screening cannot identify every genetic condition.

Some children may still need additional testing because of developmental delays, birth defects, unexplained illnesses or a relevant family history.

A normal screening result, therefore, does not mean that a child can never have a genetic disorder.

Instead, newborn screening works as an early-warning system.

If doctors later see symptoms or other warning signs, they can recommend more detailed diagnostic testing.

THE PROGRAMME CAN ALSO HELP FAMILIES

Mission ANMOL's wider genetic-health services are not limited to newborns.

The genetics department at LNJP also conducts testing for parents when doctors suspect an inherited condition within a family.

This can be particularly relevant in cases involving inherited blood disorders such as thalassemia and sickle-cell disease.

Genetic testing can help determine whether parents carry particular traits and what those findings could mean for future pregnancies.

Depending on the circumstances, doctors may recommend genetic counselling and, where medically appropriate, additional prenatal testing.

The broader aim is to move genetic healthcare away from waiting for serious illness and towards earlier risk identification and informed decisions.

THE FINANCIAL SIDE OF EARLY TESTING

For many families, genetic testing is both a medical and financial concern.

Advanced diagnostic tests can be costly, while the treatment and monitoring of rare or inherited conditions can involve expenses over many years.

Providing newborn screening free of charge removes at least one financial barrier at the earliest stage.

That could be especially valuable for families who might otherwise delay testing because of cost.

But screening is only the beginning.

If a newborn receives an abnormal result, families also need access to confirmatory testing, specialist consultations, treatment and continued follow-up.

Making sure those services are available will be one of the biggest challenges as Mission ANMOL expands.

EXPANSION WILL REQUIRE MORE THAN LABORATORIES

Taking the programme to hospitals across Delhi will require more than installing laboratory equipment.

The health system will also need:

  • Trained doctors and laboratory staff

  • Reliable sample collection

  • Efficient transportation of samples

  • Accurate laboratory processing

  • Secure storage of biological samples

  • Genetic counselling

  • Confirmatory diagnostic services

  • Specialist referrals

  • Long-term follow-up

Screening can produce thousands of results, but those results only become useful when the healthcare system can respond to them.

If a family receives an abnormal result but cannot easily access confirmatory testing or specialist care, early detection loses much of its value.

THE REAL TEST: WHAT HAPPENS AFTER SCREENING?

The success of Mission ANMOL will ultimately depend on more than the number of babies screened.

The more important question will be what happens when a screening result comes back abnormal.

Ideally, families should have a clear pathway:

SCREENING → CONFIRMATION → COUNSELLING → SPECIALIST CARE → TREATMENT → FOLLOW-UP

Finding a possible disorder is an important first step.

Making sure the child receives timely and appropriate care is what turns that screening result into a meaningful health intervention.

WHY THIS MATTERS FOR DELHI

Delhi's large and diverse population includes families who rely heavily on government healthcare.

Expanding newborn screening through government hospitals could help narrow the gap in access to specialised genetic diagnostics.

It could also increase the chances of identifying certain conditions before they lead to serious complications.

The programme reflects a broader change in healthcare: moving from treating disease after symptoms appear towards identifying potential problems earlier.

That approach is increasingly important in preventive and precision medicine.

FACT CHECK METER

FACT METER: 96%

STATUS: DEVELOPING

CONFIRMED

  • Delhi has launched Mission ANMOL as a free newborn-screening initiative.

  • The programme targets 56 genetic and congenital conditions.

  • LNJP Hospital currently houses the Delhi government's newborn genetic-screening facility.

  • Around 14,000 newborn samples are reportedly processed there each month.

  • The government has announced plans to expand genetic-testing facilities to other government hospitals.

  • The broader programme target is around 250,000 newborns screened annually.

IMPORTANT DISTINCTION

Newborn screening cannot detect every genetic condition. Some children may require additional diagnostic testing based on symptoms, family history or other clinical findings.

AWX VERDICT

Delhi's expansion of free newborn screening could significantly improve access to early genetic detection. But its long-term impact will depend on whether families can also access confirmatory testing, specialist care and treatment after an abnormal result.

AWX FOCUS

The obvious headline is about free genetic testing.

But the bigger story is about time.

For some genetic and metabolic conditions, waiting until symptoms become obvious can mean losing valuable time for intervention.

Newborn screening attempts to bring that timeline forward.

Instead of waiting to ask:

“Why is this child becoming ill?”

doctors may have an opportunity to ask much earlier:

“Could there be an underlying condition that we can identify and address now?”

That shift could have a lasting impact on child healthcare in Delhi.

WHAT TO WATCH NEXT

  • Which government hospitals receive expanded genetic-testing facilities.

  • How quickly the programme reaches more delivery centres.

  • Whether Delhi meets its annual screening target.

  • How long families wait for laboratory results.

  • Availability of genetic counselling.

  • Access to confirmatory testing after abnormal results.

  • Referral and treatment capacity for children identified through screening.

  • Whether the programme eventually reaches every newborn born in Delhi.

THE AWX BOTTOM LINE

DELHI IS TRYING TO MOVE NEWBORN HEALTHCARE FROM LATE DETECTION TO EARLY ACTION.

Mission ANMOL could make specialised genetic screening more accessible to families who might otherwise struggle with the cost or availability of such testing.

But the real measure of success will not simply be the number of blood samples collected.

It will be how many children receive the right diagnosis at the right time — and then get the care they need.

Delhi has begun building that pathway.

The next challenge is making sure it reaches families across the capital, not only those who already know where to find specialised genetic services.

ATTLAS WIRE | AWX WORLD NEWS

Real Stories. Lasting Impact.